BRCA1-deficient mammary tumor cells are dependent on EZH2 expression and sensitive to Polycomb Repressive Complex 2-inhibitor 3-deazaneplanocin A

Overview of attention for article published in Breast Cancer Research, August 2009

Altmetric Badge

Mentioned by

patent: 1 patent

Citations

dimensions_citation: 99 Dimensions

Readers on

mendeley: 116 Mendeley

Summary Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

Methods and assays for combination treatment of cancer

Grant US-9895390-B2

United States of America

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.